Annovis Targets 2027 Alzheimer’s Drug Data Readout
MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) will present updates on its experimental Alzheimer’s disease treatment buntanetap at a November medical conference in Boston as the Malvern-based biotechnology company …
Annovis Targets 2027 Alzheimer’s Drug Data Readout Read More